A high fat diet is linked to unfavourable changes in the type and numbers of gut bacteria – collectively known as the microbiome – as well as a rise in inflammatory triggers in the body, finds the first study of its kind, published online in the journal Gut.
These effects may sow the seeds for the development of metabolic disorders, such as diabetes, as well as heart disease and stroke, over the longer term, warn the researchers. The findings may be particularly important for countries where dietary habits are becoming more “Westernised”, in tandem with increasing levels of population wealth, they add.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.
